ARCHIVES

Phase III Trial Would Give Clearer Picture Of C225 Role.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

January 31, 1992

DCT Advisors Approve Five Trials For High Priority Status

April 7, 1995

Lasker Pushes NCI To Get Research Results Quicker, Into Practice Sooner

May 31, 1974

Program Announcements For Studies On Blue Collar Workers, Children Released By DRCCA

November 5, 1982

Obey Attacks NCI, Eppley, Shubick, Asks for Full Report From GAO

June 10, 1977